Investor Relations

	Live Webcast
	Q2 2008 Incyte Corporation Earnings Conference Call
	July 31, 2008  8:30 a.m. ET

Exchange   NASDAQ Change   -0.45 (4.97%)  Price   $8.60 Last Trade   Jul 24 2008 | 4:00 p.m. ET

Incyte's mission is to become one of the leaders in drug discovery.

With a management team experienced in both the pharmaceutical and biotechnology industries, exceptional scientists multiple drug discovery programs and a strong cash position, Incyte believes it is well positioned to achieve that mission.

If you would like to receive notifications about new press releases, SEC filings and financial reports, please send us your e-mail address. E-mail

Notice To Readers: Incyte's press releases, presentations and printed remarks are included on this Web site for historical purposes only. The information contained in these documents and webcasts should be considered accurate only as of the date of the relevant document or presentation. This information may change over time; therefore, visitors to this Web site should not assume that the information contained in these documents or presentations remains accurate at a later time. We do not have any current intention, and expressly disclaim any obligation, to supplement, update or revise any of the information in these documents or presentations.